BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28681976)

  • 1. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
    Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
    Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
    J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.
    Fellin F; Azzeroni R; Maggio A; Lorentini S; Cozzarini C; Di Muzio N; Fiorino C; Calandrino R; Schwarz M
    Radiother Oncol; 2013 May; 107(2):207-12. PubMed ID: 23541644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique.
    Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
    Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
    J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
    Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
    Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per-voxel constraints to minimize hot spots in linear energy transfer-guided robust optimization for base of skull head and neck cancer patients in IMPT.
    Feng H; Shan J; Anderson JD; Wong WW; Schild SE; Foote RL; Patrick CL; Tinnon KB; Fatyga M; Bues M; Patel SH; Liu W
    Med Phys; 2022 Jan; 49(1):632-647. PubMed ID: 34843119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
    Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
    Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer.
    Barsky AR; George J; Wroe AJ; Mittauer KE; Kaiser A; Herrera R; Yu J; Gutierrez AN; Alvarez D; McCulloch J; Kasper ME; Mehta MP; Chuong MD
    Med Dosim; 2024 Summer; 49(2):121-126. PubMed ID: 38001010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
    Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.